Effects of Calcium Dobesilate on Renal Injury in Patients with Diabetic Nephropathy
Yang Renyong
Abstract
Yang Renyong
Abstract
Objective: To study the effects of calcium dobesilate on renal injury in patients with diabetic nephropathy.Methods: Sixty-four cases of patients with stage Ⅲ and stage Ⅳ diabetic nephropathy were selected and were randomly divided into treatment group(1.5 g of calcium dobesilate daily) and control group.Urine albumin excretion(UAE),24-hour urine protein(TP/24h),blood rheology,alanine aminotransferase(ALT),aspartate aminotransferase(AST),blood urea nitrogen(BUN),and serum creatinine(Scr) in both groups were monitored.Results: Twelve weeks after treatment,UAE in treatment group at stage Ⅲ was(176±28) μg/min,which was significantly lower than that of control group at stage Ⅲ([126±21] μg/min,P0.05).TP/24h of treatment group at stage Ⅳ was(0.79±0.09) g(P0.05,vs [0.83±0.11] g in control group).The whole blood viscosity and plasma viscosity were decreased significantly after the treatment of calcium dobesilate in both stage Ⅲ and stage Ⅳ patients(P0.05).However,calcium dobesilate treatment didn't have significant influence on ALT,AST,BUN,and Scr(P0.05).Conclusion: Calcium dobesilate has advantages on treating patients with diabetic nephropathy stage Ⅲ.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To study the effects of calcium dobesilate on renal injury in patients with diabetic nephropathy.Methods: Sixty-four cases of patients with stage Ⅲ and stage Ⅳ diabetic nephropathy were selected and were randomly divided into treatment group(1.5 g of calcium dobesilate daily) and control group.Urine albumin excretion(UAE),24-hour urine protein(TP/24h),blood rheology,alanine aminotransferase(ALT),aspartate aminotransferase(AST),blood urea nitrogen(BUN),and serum creatinine(Scr) in both groups were monitored.Results: Twelve weeks after treatment,UAE in treatment group at stage Ⅲ was(176±28) μg/min,which was significantly lower than that of control group at stage Ⅲ([126±21] μg/min,P0.05).TP/24h of treatment group at stage Ⅳ was(0.79±0.09) g(P0.05,vs [0.83±0.11] g in control group).The whole blood viscosity and plasma viscosity were decreased significantly after the treatment of calcium dobesilate in both stage Ⅲ and stage Ⅳ patients(P0.05).However,calcium dobesilate treatment didn't have significant influence on ALT,AST,BUN,and Scr(P0.05).Conclusion: Calcium dobesilate has advantages on treating patients with diabetic nephropathy stage Ⅲ.
Key concepts: Diabetic nephropathy, Creatinine, Blood urea nitrogen, Medicine, Internal medicine, Albumin, Calcium, Urine